- CATIE NewsA long-acting formulation of cabotegravir (Apretude) has been approved for HIV prevention. This drug has been highly effective in clinical trials at significantly reducing the risk of HIV. Apretude…
- CATIE NewsResearchers surveyed more than 1,900 trans and nonbinary people in Canada about PrEP. PrEP awareness, lifetime PrEP use and current PrEP use figures were low. Improved PrEP awareness and access are…
- A study has shown that 95% of participants in a rapid HIV treatment initiation program start antiretroviral treatment (ART) within 24 hours of being diagnosed with HIV.
- CATIE NewsIn high-income countries today a significant proportion of people with HIV do not know their infection status. Here are estimates of these proportions in a few ...
- Positive SideAs CATIE turns 30, three employees reflect on their time at the organization and how it has evolved over the years.
Interviews by RonniLyn Pustil - HIV treatment and the maintenance of an undetectable viral load is a highly effective strategy to prevent HIV transmission. A person with HIV who is on successful treatment cannot pass HIV to their…
- CATIE NewsSome people take medicines to prevent or treat conditions such as diabetes and heart disease. A study found that taking many medications (polypharmacy) is linked to an increased risk of falls.…
- CATIE NewsIn clinical trials, the early initiation of HIV treatment (ART) stabilizes the immune system and significantly reduces the risk of developing AIDS-related ...
- CATIE NewsScientists have found that depression is relatively common in people with HIV. Screening and treatment for depression could increase viral suppression rates by 15%. CDC researchers recommend enhanced…
- CATIE NewsResearchers analyzed health data of Ontarians with severe kidney injury who required dialysis. Those eligible for kidney transplants were less likely to receive one if they were living with HIV.…
- CATIE NewsSeveral studies have found that some people with HIV are more likely to have mental health issues compared to HIV-negative people. Most of these studies have ...